glp 1 excessive gas Flatulence from GLP-1 Injections GLP-1 and Anesthesia: Considerations and

This review synthesizes findings from randomized controlled trials, open-label studies, and observational research examining ALC use and clinical outcomes in adults treated with ALC in MDD and BD

In terms of its effects, it appears to impact drinking in ways (though not necessarily mechanisms) similar to naltrexone (FDA-approved) and topiramate (prescribed off label for alcohol use disorder), which have a greater effect in reducing intensity of drinking on drinking days relative to their effects on whether someone drinks at all (i.e., abstinent days) although all of them do increase abstinent days to some degree on average)

This works well for higher doses (10 to 15 mg per week) where you want smaller injection volumes

doi: 10.1073/pnas.0803391105 [DOI] [PMC free article] [PubMed] [Google Scholar] 91.Harmon DE, Ruiz C, Bradford PA

The list goes on and on, so much so that its almost difficult to keep up with it

Deciphering the conformational landscape of few selected aromatic noncoded amino acids (NCAAs) for applications in rational design of peptide therapeutics